Celea Therapeutics
United States · $255.0M raised
- Total Funding
- $255.0M
- Last Round
- $180.0M Series BJul 2026
- Rounds
- 2
About
Biotech company focused on respiratory disease treatment.
Summary
Celea Therapeutics is a Biotech company based in United States. It has raised $255.0M in total across 2 rounds, most recently a $180.0M Series B round in Jul 2026. Investors include RA Capital Management, PureTech Health and Leaps by Bayer.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...